+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
RNA Sequencing Service Market: Industry Trends and Global Forecasts, Till 2035 - Distribution by Type of Sequencing Method, Application Area, End User Industry and Key Geographical Regions- Product Image
RNA Sequencing Service Market: Industry Trends and Global Forecasts, Till 2035 - Distribution by Type of Sequencing Method, Application Area, End User Industry and Key Geographical Regions- Product Image
New

RNA Sequencing Service Market: Industry Trends and Global Forecasts, Till 2035 - Distribution by Type of Sequencing Method, Application Area, End User Industry and Key Geographical Regions

  • PDF Icon

    Report

  • 196 Pages
  • December 2025
  • Region: Global
  • Roots Analysis
  • ID: 6214399
Description Jump to:
The RNA sequencing service market is USD is projected to grow from USD 3.3 billion in the current year and is expected to reach USD 7.5 billion by 2035, representing a CAGR of 8.4% during the forecast period.

RNA SEQUENCING SERVICES MARKET: GROWTH AND TRENDS

RNA sequencing was initially presented by Fredrick Sanger in 1977, utilizing the chain termination technique, also referred to as the Sanger sequencing method or first-generation sequencing method. It is a rapid technique that allows for the profiling of the complete spectrum of RNA produced by the cell, with enhanced coverage and resolution. Although, the Sanger sequencing technique is more expensive than alternative methods and has limited detection capability, which diminishes its scalability. With time, the RNA sequencing service market has undergone numerous technological advancements, and various RNA sequencing methods are currently employed for differential gene and allele-specific expression, small RNA profiling, characterization of alternative splicing patterns, and systems biology.

Among different sequencing techniques, next generation sequencing (NGS) launched by Lynx Therapeutics in 2000, has become a favored option throughout the industry. It is a parallel genome sequencing technology with high throughput that allows for whole genome and whole exome sequencing. It allows for a decrease in total cost and processing duration. Even with numerous technological progressions in RNA sequencing, there are several persistent issues, such as challenges in sequencing large genes, a scarcity of human resources, and insufficient tools for data manipulation and analysis. Moreover, the development and maintenance of facilities based on next generation sequencing demand significant investment. To address these challenges and achieve a high-quality result, industry players view the outsourcing of RNA sequencing as a more favorable choice compared to other options.

At present, over 70 firms provide services associated with RNA sequencing. Several of these firms are new ventures that were founded in the last ten years. Moreover, various stakeholders are involved in developing their proprietary technologies to address the issues associated with amplification and duplication rates during sequencing. Additionally, more than 340 patents concerning RNA sequencing have been recently issued or filed, showcasing the innovation.

Further, in recent years, the National Institutes of Health have awarded grants worth USD 486 million to bolster the ongoing R&D initiatives in the RNA sequencing service sector. Fueled by the increasing interest from diverse stakeholders and the broad applicability of this technique, we expect that the RNA sequencing services sector will experience significant market growth in the forecast period.

RNA SEQUENCING SERVICE MARKET: KEY INSIGHTS

The report delves into the current state of the RNA sequencing service market and identifies potential growth opportunities within industry. Some key findings from the report include:
  • Close to 75 players, across the globe, claim to offer services for RNA sequencing; a relatively larger proportion of these players are start ups / small companies, established in the US post 2010.

  • Majority of the service providers (38%) offer services for sequencing of small RNA and mRNA; Illumina is the most widely employed platform for sequencing different RNA samples.
  • In pursuit of building a competitive edge, stakeholders are striving to enhance their service portfolio and upgrade their facilities with advanced sequencing platforms.
  • More than 340 patents related to RNA sequencing have been filed / granted by various stakeholders in order to protect the intellectual property generated within this field.
  • Over the past few years, grants worth USD 1.03 billion have been awarded to various organizations in order to support the ongoing research and innovation efforts.

  • RNA sequencing for transcriptome profiling has become a widely used technique in life sciences industry, leading to an increase in opportunities within this domain.
  • Sequencing platforms with less turnaround time are likely to have high profitability index and offer more profit potential to the companies offering RNA sequencing services.
  • The RNA sequencing services market is expected to grow at a rate of 8.4%, till 2035; the market opportunity is likely to be well distributed across different methods, applications, end-users and geographies.

RNA SEQUENCING SERVICE MARKET: MARKET SEGMENTS

Next Generation Sequencing Service Market is Likely to Capture the Majority of the RNA Sequencing Service Market

In terms of type of sequencing method, the next generation sequencing service market is segmented across next generation sequencing methods and other methods. Currently, majority of the market share is captured by next generation sequencing methods constituting nearly 95% of the market and the trend is likely to remain the same during the forecast period.

Majority of the RNA Sequencing Service Market Share is Captured by Hospitals

In terms of type of end user, the RNA sequencing services market is segmented across hospitals and clinics, pharmaceutical and biotechnology companies, academic and research institutes and others. Currently, majority of the market share is captured by hospitals constituting around 45% of the market share. The segment is likely to grow at a notable CAGR during the period.

North America is Likely to Dominate the RNA Sequencing Service Market

In terms of type of geographical regions, the RNA sequencing services market is segmented across North America, Europe, Asia-Pacific, Latin America and MENA. Currently, majority (37%) of the market share is captured by North America and the trend is unlikely to change in the future.

Example Players in the RNA Sequencing Services Market

  • Admera Health
  • Biogazelle (acquired by CellCarta)
  • CD Genomics
  • Creative Biogene
  • IGA Technology
  • LC Sciences
  • Lexogen
  • Novogene
  • Otogenetics
  • Yaazh Xenomic

RNA SEQUENCING SERVICES MARKET: RESEARCH COVERAGE

  • Market Sizing and Opportunity Analysis: The report features an in-depth analysis of the RNA sequencing services market, focusing on key market segments, including [A] type of sequencing method, [B] application area, [C] end user industry, and [D] key geographical regions.
  • Market Landscape: A detailed analysis of the overall market landscape of RNA sequencing service providers based on several relevant parameters, such as [A] year of establishment, [A] company size, [B] location of headquarters, [C] type of RNA sequencing service(s), type of platform, [D] turnaround time, [E] type of sample and [F] volume of sample.
  • Company Competitiveness Analysis: A comprehensive competitive analysis of RNA sequencing service providers, examining factors, such as [A] company strength and [B] service portfolio strength.
  • Company Profiles: In-depth profiles of prominent players offering providing services for RNA sequencing, headquartered in North America, Europe and Asia-Pacific focusing on [A] year of establishment, [B] location of headquarters, [C] product portfolio, [D] recent developments and [E] an informed future outlook.
  • Grants Analysis: A detailed analysis of grants awarded to various research institutes for projects related to RNA sequencing, based on several relevant parameters, such as [A] year of grant awarded, [B] amount awarded, [C] administering institute center, [D] support period, [E] type of grant application, [F] purpose of grant, [G] activity code, [H] study section, [I] type of organization, [J] emerging focus areas, [K] popular NIH departments, [L] popular recipient organizations (in terms of number of grants and amount awarded), [M] prominent program officers and [N] location of recipient organizations.
  • Patent Analysis: An insightful analysis of patents filed / granted for RNA sequencing, since 2018, taking into consideration various relevant parameters, such as [A] type of patent, [B] publication year, [C] application year, [D] geographical location, [E] CPC symbols, [F] emerging focus areas, [G] type of applicant, [H] leading players and [I] individual assignees (in terms of number of patents granted / filed in the given time period).
  • Porter’s Five Forces Analysis: A qualitative analysis of the five competitive forces, including [A] threats of new entrants, [B] bargaining power of customers, [C] bargaining power of RNA sequencing service providers, [D] threats of substitute services and [E] rivalry among existing competitors under an insightful Porter’s Five Forces framework.

KEY QUESTIONS ANSWERED IN THIS REPORT

  • How many companies are currently engaged in this market?
  • Which are the leading companies in this market?
  • What factors are likely to influence the evolution of this market?
  • What is the current and future market size?
  • What is the CAGR of this market?
  • How is the current and future market opportunity likely to be distributed across key market segments?

REASONS TO BUY THIS REPORT

  • The report provides a comprehensive market analysis, offering detailed revenue projections of the overall market and its specific sub-segments. This information is valuable to both established market leaders and emerging entrants.
  • Stakeholders can leverage the report to gain a deeper understanding of the competitive dynamics within the market. By analyzing the competitive landscape, businesses can make informed decisions to optimize their market positioning and develop effective go-to-market strategies.
  • The report offers stakeholders a comprehensive overview of the market, including key drivers, barriers, opportunities, and challenges. This information empowers stakeholders to stay abreast of market trends and make data-driven decisions to capitalize on growth prospects.

ADDITIONAL BENEFITS

  • Complimentary PPT Insights Packs
  • Complimentary Excel Data Packs for all Analytical Modules in the Report
  • 15% Free Content Customization
  • Detailed Report Walkthrough Session with the Research Team
  • Free Updated report if the report is 6-12 months old or older

Table of Contents

1. PREFACE
1.1. Scope of the Report
1.2. Market Segmentation
1.3. Research Methodology
1.4 Key Questions Answered
1.5. Chapter Outlines
2. EXECUTIVE SUMMARY
3. INTRODUCTION
3.1. Chapter Overview
3.2. An Overview of RNA Sequencing
3.2.1. Key Steps Involved in RNA Sequencing
3.2.2. Types of RNA Sequencing
3.2.2.1. Single End Sequencing
3.2.2.2. Paired End Sequencing
3.2.3. Methods of RNA Sequencing
3.2.3.1. First Generation Sequencing
3.2.3.2. Next Generation Sequencing
3.2.3.3. Third Generation Sequencing
3.2.4. Applications of RNA Sequencing
3.2.5. Advantages of RNA Sequencing
3.2.6. Limitations of RNA Sequencing
3.2.7. RNA Sequencing Platforms
3.2.7.1. Illumina Sequencing Platforms
3.2.7.2. Pac Bio Sequencing Platforms
3.2.7.3. Nanopore Sequencing Platforms
3.3. Concluding Remarks
4. RNA SEQUENCING SERVICE PROVIDERS: MARKET OVERVIEW
4.1. Chapter Overview
4.1.1. RNA Sequencing Service Providers
4.1.2. Analysis by Year of Establishment
4.1.3. Analysis by Company Size
4.1.4. Analysis by Location of Headquarters
4.1.5. Analysis by Company Size and Region of Headquarters
4.1.6. Analysis by Type of RNA Sequencing Service(s)
4.1.7. Analysis by Type of Platform
4.1.8. Analysis by Turnaround Time
4.1.9. Analysis by Type of Sample
4.1.10. Analysis by Amount of Sample
5. COMPANY COMPETITIVENESS ANALYSIS
5.1. Chapter Overview
5.2. Assumptions and Key Parameters
5.3. Scope and Methodology
5.4. Company Competitiveness Analysis: RNA Sequencing Service Providers in North America
5.5. Company Competitiveness Analysis: RNA Sequencing Service Providers in Europe
5.6. Company Competitiveness Analysis: RNA Sequencing Service Providers in Asia-Pacific and Rest of the World
6. COMPANY PROFILES
6.1. Chapter Overview
6.2. Admera Health
6.2.1. Company Overview
6.2.2. RNA Sequencing Service Portfolio
6.2.3. Recent Developments and Future Outlook
6.3. Biogazelle (acquired by CellCarta)
6.3.1. Company Overview
6.3.2. RNA Sequencing Service Portfolio
6.3.3. Recent Developments and Future Outlook
6.4. CD Genomics
6.4.1. Company Overview
6.4.2. RNA Sequencing Service Portfolio
6.4.3. Recent Developments and Future Outlook
6.5. Creative Biogene
6.5.1. Company Overview
6.5.2. RNA Sequencing Service Portfolio
6.5.3. Recent Developments and Future Outlook
6.6. IGA Technology
6.6.1. Company Overview
6.6.2. RNA Sequencing Service Portfolio
6.6.3. Recent Developments and Future Outlook
6.7. LC Sciences
6.7.1. Company Overview
6.7.2. RNA Sequencing Service Portfolio
6.7.3. Recent Developments and Future Outlook
6.8. Lexogen
6.8.1. Company Overview
6.8.2. RNA Sequencing Service Portfolio
6.8.3. Recent Developments and Future Outlook
6.9. Novogene
6.9.1. Company Overview
6.9.2. RNA Sequencing Service Portfolio
6.9.3. Recent Developments and Future Outlook
6.10. Otogenetics
6.10.1. Company Overview
6.10.2. RNA Sequencing Service Portfolio
6.10.3. Recent Developments and Future Outlook
6.11. Yaazh Xenomic
6.11.1. Company Overview
6.11.2. RNA Sequencing Service Portfolio
6.11.3. Recent Developments and Future Outlook
7. ACADEMIC GRANT ANALYSIS
7.1. Chapter Overview
7.2. Scope and Methodology
7.3. Analysis by Year of Grant Award
7.3.1. Analysis by Amount Awarded
7.3.2. Analysis by Administering Institute Centre
7.3.3. Analysis by Support Period
7.3.4. Analysis by Administering Institute Centre and Support Period
7.3.5. Analysis by Type of Grant Application
7.3.6. Analysis by Purpose of Grant
7.3.7. Analysis by Purpose of Grant and Amount Awarded
7.3.8. Analysis by Activity Code
7.3.9. Analysis by Study Section Involved
7.3.10. Analysis by Type of Organization
7.3.11. Word Cloud: Emerging Focus Areas
7.3.12. Most Popular Departments: Analysis by Number of Grants
7.3.13. Prominent Program Officers: Analysis by Number of Grants
7.3.14. Popular Recipient Organizations: Analysis by Number of Grants
7.3.15. Popular Recipient Organizations: Analysis by Amount Awarded
7.3.16. Analysis of Recipient Organizations located in the US
8. PATENT ANALYSIS
8.1. Chapter Overview
8.2. Scope and Methodology
8.3. RNA Sequencing: Patent Analysis
8.3.1. Analysis by Publication Year
8.3.2. Analysis by Application Year
8.3.3. Analysis by Annual Number of Granted Patents and Patent Applications
8.3.4. Analysis by Geography
8.3.5. Analysis by CPC Symbols
8.3.6. Analysis by Focus Area
8.3.7. Analysis by Type of Applicant
8.3.8. Leading Players: Analysis by Number of Patents
8.3.9. Leading Individual Assignees: Analysis by Number of Patents
8.4. RNA Sequencing: Patent Benchmarking Analysis
8.4.1. Analysis by Patent Characteristics
8.5. RNA sequencing: Patent Valuation Analysis
8.6. Leading Patents: Analysis by Number of Citations
9. PORTER’S FIVE FORCES ANALYSIS
9.1. Chapter Overview
9.2. Methodology and Assumptions
9.3. Key Parameters
9.3.1. Threats of New Entrants
9.3.2. Power of Customers
9.3.3. Power of RNA Sequencing Service Providers
9.3.4. Threats of Substitute Services
9.3.5. Rivalry Among Existing Competitors
9.4. Concluding Remarks
10. CASE STUDY: NGS LIBRARY PREPARATION KITS
10.1. Chapter Overview
10.2. NGS Library Preparation Kits: Overall Market Landscape
10.2.1. Analysis by Type of Platform
10.2.2. Analysis by Amount of Sample
10.2.3. Analysis by Turnaround Time
10.2.4. Analysis by Storage Temperature
10.2.5. Analysis by Type of Sequencing
10.2.6. Analysis by Kit Components
10.2.7. Analysis by Type of Sample
10.3. NGS Library Preparation Kits: Developer Landscape
10.3.1. Analysis by Year of Establishment
10.3.2. Analysis by Company Size
10.3.3. Analysis by Region of Headquarters
11. INVESTMENT POTENTIAL ANALYSIS
11.1. Chapter Overview
11.2. Scope and Methodology
11.3. Profit Potential of Commonly used RNA Sequencing Platforms
11.2.1. iSeq: Likely Profit Potential
11.2.2. MiSeq: Likely Profit Potential
11.2.3. NextSeq 550 Series: Likely Profit Potential
11.2.4. NextSeq 1000: Likely Profit Potential
11.2.5. NextSeq 1000: Likely Profit Potential
11.2.6. Sequel: Likely Profit Potential
11.2.7. Sequel II: Likely Profit Potential
11.2.8. Sequel IIe: Likely Profit Potential
11.4. Payback Evaluation Matrix
11.3. Conclusion
12. MARKET SIZING AND OPPORTUNITY ANALYSIS
12.1. Chapter Overview
12.2. Forecast Methodology and Key Assumptions
12.3. Global RNA Sequencing Services Market, Till 2035
12.3.1. RNA Sequencing Services Market, Till 2035: Distribution by Type of Sequencing Method
12.3.1.1. RNA Sequencing Services Market for Next Generation Sequencing Methods, Till 2035
12.3.1.2. RNA Sequencing Services Market for Other Methods, Till 2035
12.3.2. RNA Sequencing Services Market, Till 2035: Distribution by Type of Application Area
12.3.2.1. RNA Sequencing Services Market for Research Purposes, Till 2035
12.3.2.2. RNA Sequencing Services Market for Diagnostic Purposes, Till 2035
12.3.3. RNA Sequencing Services Market, Till 2035: Distribution by Type of End User Industry
12.3.3.1. RNA Sequencing Services Market for Academic and Research Industry, Till 2035
12.3.3.2. RNA Sequencing Services Market for Clinics and Hospitals, Till 2035
12.3.3.3. RNA Sequencing Services Market for Pharmaceutical Industry, Till 2035
12.3.3.4. RNA Sequencing Services Market for Other Users, Till 2035
12.3.4. RNA Sequencing Services Market, Till 2035: Distribution by Key Geographical Regions
12.3.4.1. RNA Sequencing Services Market in North America, Till 2035
12.3.4.2. RNA Sequencing Services Market in Europe, Till 2035
12.3.4.3. RNA Sequencing Services Market in Asia-Pacific, Till 2035
12.3.4.4. RNA Sequencing Services Market in Latin America, Till 2035
12.3.4.5. RNA Sequencing Services Market in Middle East and North Africa, Till 2035
13. EXECUTIVE INSIGHTS14. APPENDIX 1: TABULATED DATA15. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS
LIST OF FIGURES
Figure 3.1 Key Steps Involved in RNA Sequencing
Figure 4.1 RNA Sequencing Service Providers: Distribution by Year of Establishment
Figure 4.2 RNA Sequencing Service Providers: Distribution by Company Size
Figure 4.3 RNA Sequencing Service Providers: Distribution by Location of Headquarters (Region Wise)
Figure 4.4 RNA Sequencing Service Providers: Distribution by Location of Headquarters (Country Wise)
Figure 4.5 RNA Sequencing Service Providers: Distribution by Company Size and Region of Headquarters
Figure 4.6 RNA Sequencing Service Providers: Distribution by Type of RNA Sequencing Service(s) Offered
Figure 4.7 RNA Sequencing Service Providers: Distribution by Platform
Figure 4.8 RNA Sequencing Service Providers: Distribution by Type of RNA Sequencing Service(s) and Type of Platform
Figure 4.9 RNA Sequencing Service Providers: Distribution by Turnaround Time
Figure 4.10 RNA Sequencing Service Providers: Distribution by Type of Sample
Figure 4.11 RNA Sequencing Service Providers: Distribution by Type of RNA Sequencing Services(s) and Type of Sample
Figure 4.12 RNA Sequencing Service Providers: Distribution by Amount of Sample (in mg)
Figure 4.13 RNA Sequencing Service Providers: Distribution by Type of RNA Sequencing Services(s) and Amount of Sample
Figure 5.1 Company Competitiveness Analysis: RNA Sequencing Service Providers in North America
Figure 5.2 Company Competitiveness Analysis: RNA Sequencing Service Providers in Europe
Figure 5.3 Company Competitiveness Analysis: RNA Sequencing Service Providers in Asia-Pacific
Figure 7.1 Grant Analysis: Cumulative Year-Wise Trend, 2017-2022
Figure 7.2 Grant Analysis: Distribution by Amount Awarded (USD Million)
Figure 7.3 Grant Analysis: Distribution by Administering Institute Centre
Figure 7.4 Grant Analysis: Distribution by Support Period
Figure 7.5 Grant Analysis: Distribution by Administering Institute Centre and Support Period
Figure 7.6 Grant Analysis: Distribution by Type of Grant Application
Figure 7.7 Grant Analysis: Distribution by Purpose of Grant Award
Figure 7.8 Grant Analysis: Distribution of Amount Awarded by Purpose of Grant (USD Million)
Figure 7.9 Grant Analysis: Distribution by Activity Code
Figure 7.10 Grant Analysis: Distribution by Study Section Involved
Figure 7.11 Grant Analysis: Distribution by Type of Organization
Figure 7.12 Most Popular Departments: Distribution by Number of Grants
Figure 7.13 Word Cloud: Emerging Focus Areas
Figure 7.14 Prominent Program Officers: Distribution by Number of Grants
Figure 7.15 Popular Recipient Organizations: Distribution by Number of Grants
Figure 7.16 Popular Recipient Organization: Distribution by Amount Awarded (USD Million)
Figure 7.17 Grant Analysis: Distribution of Recipient Organizations located in US
Figure 8.1 Patent Analysis: Distribution by Type of Patent
Figure 8.2 Patent Analysis: Cumulative Distribution by Publication Year, 2018-2022
Figure 8.3 Patent Analysis: Cumulative Distribution by Application Year, Pre-2016 - 2022
Figure 8.4 Patent Analysis: Distribution by Annual Number of Granted Patents and Patent Applications, 2018-2022
Figure 8.5 Patent Analysis: Distribution by Geography
Figure 8.6 Patent Analysis: Distribution by CPC Symbols
Figure 8.7 Word Cloud: Emerging Focus Areas
Figure 8.8 Patent Analysis: Cumulative Year-wise Distribution by Type of Applicant
Figure 8.9 Leading Industry Players: Distribution by Number of Patents
Figure 8.10 Leading Non-Industry Players: Distribution by Number of Patents
Figure 8.11 Patent Analysis: Leading Individual Assignees
Figure 8.12 Leading Industry Players: Benchmarking by Patent Characteristics (CPC Symbols)
Figure 8.13 Patent Analysis: Distribution by Patent Age
Figure 8.14 Patent Valuation Analysis
Figure 9.1 Porter’s Five Forces: Key Parameters
Figure 9.2 Porter’s Five Forces: Harvey Ball Analysis
Figure 10.1 NGS Library Preparation Kits: Distribution by Type of Platform
Figure 10.2 NGS Library Preparation Kits: Distribution by Amount of Sample
Figure 10.3 NGS Library Preparation Kits: Distribution by Turnaround Time
Figure 10.4 NGS Library Preparation Kits: Distribution by Storage Temperature
Figure 10.5 NGS Library Preparation Kits: Distribution by Type of Sequencing
Figure 10.6 NGS Library Preparation Kits: Distribution by Kit Components
Figure 10.7 NGS Library Preparation Kits: Distribution by Type of Sample
Figure 10.8 NGS Library Preparation Kit Providers: Distribution by Year of Establishment
Figure 10.9 NGS Library Preparation Kit Providers: Distribution by Company Size
Figure 10.10 NGS Library Preparation Kit Providers: Distribution by Location of Headquarters
Figure 11.1 Likely Profit Potential of iSeq platform
Figure 11.2 Likely Profit Potential of MiSeq platform
Figure 11.3 Likely Profit Potential of NextSeq 550 Series platform
Figure 11.4 Likely Profit Potential of NextSeq 1000 platform
Figure 11.5 Likely Profit Potential of NextSeq 2000 platform
Figure 11.6 Likely Profit Potential of Sequel platform
Figure 11.7 Likely Profit Potential of Sequel II platform
Figure 11.8 Likely Profit Potential of Sequel IIe platform
Figure 11.9 Payback Evaluation Matrix
Figure 12.1 Global RNA Sequencing Services Market, Till 2035 (USD Billion)
Figure 12.2 RNA Sequencing Services Market, 2022 and 2035: Distribution by Type of Sequencing Method
Figure 12.3 RNA Sequencing Services Market for Next Generation Sequencing Method, Till 2035 (USD Billion)
Figure 12.4 RNA Sequencing Services Market for Other Method, Till 2035 (USD Billion)
Figure 12.5 RNA Sequencing Services Market, 2022 and 2035: Distribution by Type of Application
Figure 12.6 RNA Sequencing Services Market for Research Purposes, Till 2035 (USD Billion)
Figure 12.7 RNA Sequencing Services Market for Diagnostic Purposes, Till 2035 (USD Billion)
Figure 12.8 RNA Sequencing Services Market, 2022 and 2035: Distribution by Type of End User
Figure 12.9 RNA Sequencing Services Market for Academic and Research Industry, Till 2035 (USD Billion)
Figure 12.10 RNA Sequencing Services Market for Clinics and Hospitals, Till 2035 (USD Billion)
Figure 12.11 RNA Sequencing Services Market for Pharmaceutical Industry, Till 2035 (USD Billion)
Figure 12.12 RNA Sequencing Services Market for Other Users, Till 2035 (USD Billion)
Figure 12.13 RNA Sequencing Services Market, 2022 and 2035: Distribution by Key Geographical Regions
Figure 12.14 RNA Sequencing Services Market in North America, Till 2035 (USD Billion)
Figure 12.15 RNA Sequencing Services Market in Europe, Till 2035 (USD Billion)
Figure 12.16 RNA Sequencing Services Market in Asia-Pacific, Till 2035 (USD Billion)
Figure 12.17 RNA Sequencing Services Market in Latin America, Till 2035 (USD Billion)
Figure 12.18 RNA Sequencing Services Market in Middle East and North Africa, Till 2035 (USD Billion)

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abclonal
  • Active Motif
  • Admera Health
  • Agendia
  • Agilent Technologies
  • AgriGenome Labs
  • Allen Institute
  • Almac
  • Applied Biological Materials
  • Arraystar
  • Australian Genome Research Facility (AGRF)
  • Back Bay Life Science Advisors
  • BaseClear
  • BGI
  • Bioarray Genetics
  • BioCat
  • BioChain
  • BioDynami
  • Biogazelle (acquired by CellCarta)
  • Biokart India
  • Bioneer
  • Bio-Rad
  • Bioserve Biotechnologies (a subsidiary of Reprocell Company)
  • Brigham and Women's Hospital
  • C2i Genomics
  • CD Genomics
  • CeGaT
  • Celemics
  • Cellecta
  • Clevergene Biocorp
  • Columbia University Health Sciences
  • Creative Biogene
  • Creative Biolabs
  • Creative BioMart
  • CureVac
  • DiaCarta
  • Diagenode (acquired by Hologic)
  • Diagnomics
  • DNA Link
  • DNAVision
  • Duke Center for Genomic and Computational Biology
  • Eclipse Bioinnovations
  • Enzo Life Sciences
  • Eremid Research Services
  • Eurofins Genomics
  • Fasteris
  • Firalis
  • Fluidigm
  • Frontage Laboratories
  • Garvan Institute of Medical Research
  • GB HealthWatch
  • GCC Biotech
  • GENEWIZ (acquired by Azenta Life Sciences)
  • Genome Quebec
  • GenomeScan
  • Genome Technology Access Center (a part of Washington University)
  • Genomix4Life
  • Genotypic Technology
  • GenXPro
  • Grail
  • Harvard Medical School
  • Icahn School of Medicine
  • IGA Technology Services
  • Illumina
  • IntegraGen (acquired by OncoDNA)
  • Integrated DNA Technologies
  • Isogen Life Science
  • Johns Hopkins University
  • Koninklijke Philips
  • LC Sciences
  • Lexogen
  • Loop Genomics
  • Macrogen
  • Massachusetts General Hospital
  • Massachusetts Institute of Technology (MIT)
  • Mayo Clinic
  • MedGenome
  • Memorial Sloan Kettering Cancer Center
  • Messenger Biopharma
  • MGI
  • Microsynth
  • Molecular Research (MR DNA)
  • myGenomics
  • New England Biolabs (NEB)
  • Norgen Biotek
  • Novogene
  • Nucleome Informatics
  • Omega Bioservices
  • Otogenetics
  • Oxford Nanopore Technologies
  • Pacific Biosciences (PacBio)
  • PerkinElmer
  • PhalanxBio (a subsidiary of Phalanx Biotech)
  • Psomagen
  • Q2 Solutions
  • QIAGEN
  • Quick Biology
  • RealSeq Biosciences
  • RefGen Biotechnology
  • RNA Society
  • Roche
  • SeqMatic
  • Source BioScience
  • SRM Institute of Science and Technology
  • Stanford University
  • Swift Biosciences (acquired by Integrated DNA Technologies)
  • System Biosciences (SBI)
  • Takara Bio
  • TAmiRNA
  • Tecan
  • Thermo Fisher Scientific
  • TIANGEN Biotech
  • TriLink BioTechnologies
  • Ultima Genomics
  • University of California
  • University of Pennsylvania
  • Vazyme Biotech
  • Xcelris Genomics
  • Yaazh Xenomics
  • Yale University
  • YouSeq
  • Zymo Research

Methodology

 

 

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages196
PublishedDecember 2025
Forecast Period2025 - 2035
Estimated Market Value ( USD ) in 2025 $ 3.3 Billion
Forecasted Market Value ( USD ) by 2035 $ 7.5 Billion
Compound Annual Growth Rate8.4%
Regions CoveredGlobal

Related Topics

Related Reports

NGS-Based RNA-Sequencing Market Report 2025 - Product Image

NGS-Based RNA-Sequencing Market Report 2025

  • Report
  • 200 Pages
  • Global
From
NGS-Based RNA-Sequencing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Image

NGS-Based RNA-Sequencing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • 112 Pages
  • Global
From
Ngs-Based Rna-Sequencing Market Outlook 2026-2034: Market Share, and Growth Analysis - Product Image

Ngs-Based Rna-Sequencing Market Outlook 2026-2034: Market Share, and Growth Analysis

  • Report
  • 160 Pages
  • Global
From
NGS-Based RNA-Sequencing Market - Global Forecast 2025-2032 - Product Image

NGS-Based RNA-Sequencing Market - Global Forecast 2025-2032

  • Report
  • 182 Pages
  • Global
From
miRNA Sequencing and Assay Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

miRNA Sequencing and Assay Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 270 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.